Newer Therapies in Psoriasis.
Med Clin North Am
; 105(4): 627-641, 2021 Jul.
Article
em En
| MEDLINE
| ID: mdl-34059242
ABSTRACT
Psoriasis is a systemic inflammatory condition that negatively affects the quality of life and medical health of 125 million individuals globally. Although psoriasis has historically been viewed as a skin-limited disease and managed with topical agents (eg, coal tar, corticosteroids, and vitamin D analogues), the recontextualization of psoriasis as a systemic condition involving multiple organ systems has prompted the development of numerous immunomodulating, systemic agents with more targeted mechanisms of action. This article briefly discusses the indications and nuances of new and developing therapeutic agents for psoriasis management.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Psoríase
/
Interleucinas
/
Fator de Necrose Tumoral alfa
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
En
Revista:
Med Clin North Am
Ano de publicação:
2021
Tipo de documento:
Article